Visual storytelling for medical publications
2022-10-06 08:59

Positive Results for Aflibercept Biosimilars Seen at AAO 2022

Increase in dose and extending dosing interval for aflibercept did no impact functional outcomes in #DME and #nAMD patients, while being well tolerated
#VisualAbstract #AAO2022